-
2014[International teaching and training program in the international network of Pasteur Institutes], Med Sci (Paris) 2014 Feb;30(2):194-8.
-
2000Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein, Vaccine 2000 Nov;19(7-8):684-93.
-
1998Fine specificity of anti-V3 antibodies induced in chimpanzees by HIV candidate vaccines, AIDS Res. Hum. Retroviruses 1998 Aug;14(12):1023-34.
-
1997Restricted specificity of anti-V3 antibodies induced in humans by HIV candidate vaccines, AIDS Res. Hum. Retroviruses 1997 Nov;13(17):1471-85.
-
1994Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigs, Br. J. Pharmacol. 1994 Nov;113(3):749-56.
-
1994Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor, Mol. Cell. Biol. 1994 Aug;14(8):5023-31.
-
1994Modulation of the enhanced migration of eosinophils from the airways of sensitized guinea pigs: role of IL-5, Ann. N. Y. Acad. Sci. 1994 May;725:274-81.
-
1992Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro, J. Leukoc. Biol. 1992 May;51(5):425-31.
-
1991Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists, J. Immunol. 1991 Oct;147(8):2595-602.
-
1991LTB4, a potent chemotactic factor for purified guinea-pig eosinophils: interference of PAF-acether antagonists, Int. J. Immunopharmacol. 1991;13(2-3):273-80.
-
1990Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation, J. Leukoc. Biol. 1990 Mar;47(3):234-43.
-
1988Pharmacological profile of 48740 R.P., a PAF-acether antagonist, Eur. J. Pharmacol. 1988 Jun;150(3):257-68.
-
1987Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils, Br. J. Pharmacol. 1987 Oct;92(2):393-406.
-
1987Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets, Bull Eur Physiopathol Respir 1987 Jul-Aug;23(4):347-51.
-
1987Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity, J. Med. Chem. 1987 May;30(5):792-7.
-
1986Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs, Eur. J. Pharmacol. 1986 Nov;131(2-3):179-88.
-
1986Transient activation of the acetyltransferase necessary for paf-acether biosynthesis in thrombin-activated platelets, Br. J. Haematol. 1986 Apr;62(4):641-51.
-
1986[A rapid method: the 100-hue test], J Fr Ophtalmol 1986;9(5):385-94.
-
1985Role of paf-acether and related ether-lipid metabolism in platelets, Adv. Exp. Med. Biol. 1985;192:309-26.
-
1984Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine, Biochem. Biophys. Res. Commun. 1984 Oct;124(2):637-43.
-
1983Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils, Eur. J. Pharmacol. 1983 Apr;89(1-2):19-26.
-
1983Effect of structural analogues of PAF-acether on platelet desensitization, Br. J. Haematol. 1983 Mar;53(3):513-21.
-
1983The enantiomer and the positional isomer of platelet-activating factor, Biochim. Biophys. Acta 1983 Feb;755(3):526-30.
-
1981Synthesis and biological activity of some structural analogs of platelet-activating factor (PAF-acether), Agents Actions 1981 Dec;11(6-7):558-9.
-
1981New total synthesis and high resolution 1H NMR spectrum of platelet-activating factor, its enantiomer and racemic mixtures, Biochim. Biophys. Acta 1981 Nov;666(2):230-7.
-
1981Structural analogs of platelet-activating factor (PAF-acether), Biochimie 1981 Aug-Sep;63(8-9):723-7.